Literature DB >> 35048983

Oral Contraceptives and BRCA Cancer: A Balancing Act.

Joanne Kotsopoulos1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35048983      PMCID： PMC9002274          DOI： 10.1093/jnci/djac006

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  21 in total

1.  Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers.

Authors:  Joanne Kotsopoulos; Jan Lubinski; Pal Moller; Henry T Lynch; Christian F Singer; Charis Eng; Susan L Neuhausen; Beth Karlan; Charmaine Kim-Sing; Tomasz Huzarski; Jacek Gronwald; Jeanna McCuaig; Leigha Senter; Nadine Tung; Parviz Ghadirian; Andrea Eisen; Dawna Gilchrist; Joanne L Blum; Dana Zakalik; Tuya Pal; Ping Sun; Steven A Narod
Journal:  Breast Cancer Res Treat       Date:  2014-01-24       Impact factor: 4.872

2.  Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.

Authors:  Amy P M Finch; Jan Lubinski; Pål Møller; Christian F Singer; Beth Karlan; Leigha Senter; Barry Rosen; Lovise Maehle; Parviz Ghadirian; Cezary Cybulski; Tomasz Huzarski; Andrea Eisen; William D Foulkes; Charmaine Kim-Sing; Peter Ainsworth; Nadine Tung; Henry T Lynch; Susan Neuhausen; Kelly A Metcalfe; Islay Thompson; Joan Murphy; Ping Sun; Steven A Narod
Journal:  J Clin Oncol       Date:  2014-02-24       Impact factor: 44.544

3.  Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

Authors:  Nasim Mavaddat; Susan Peock; Debra Frost; Steve Ellis; Radka Platte; Elena Fineberg; D Gareth Evans; Louise Izatt; Rosalind A Eeles; Julian Adlard; Rosemarie Davidson; Diana Eccles; Trevor Cole; Jackie Cook; Carole Brewer; Marc Tischkowitz; Fiona Douglas; Shirley Hodgson; Lisa Walker; Mary E Porteous; Patrick J Morrison; Lucy E Side; M John Kennedy; Catherine Houghton; Alan Donaldson; Mark T Rogers; Huw Dorkins; Zosia Miedzybrodzka; Helen Gregory; Jacqueline Eason; Julian Barwell; Emma McCann; Alex Murray; Antonis C Antoniou; Douglas F Easton
Journal:  J Natl Cancer Inst       Date:  2013-04-29       Impact factor: 13.506

4.  Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.

Authors:  S A Narod; H Risch; R Moslehi; A Dørum; S Neuhausen; H Olsson; D Provencher; P Radice; G Evans; S Bishop; J S Brunet; B A Ponder
Journal:  N Engl J Med       Date:  1998-08-13       Impact factor: 91.245

5.  Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls.

Authors:  V Beral; R Doll; C Hermon; R Peto; G Reeves
Journal:  Lancet       Date:  2008-01-26       Impact factor: 79.321

6.  Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers.

Authors:  Joanne Kotsopoulos; Jacek Gronwald; Beth Y Karlan; Tomasz Huzarski; Nadine Tung; Pal Moller; Susan Armel; Henry T Lynch; Leigha Senter; Andrea Eisen; Christian F Singer; William D Foulkes; Michelle R Jacobson; Ping Sun; Jan Lubinski; Steven A Narod
Journal:  JAMA Oncol       Date:  2018-08-01       Impact factor: 31.777

7.  Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study.

Authors:  Lieske H Schrijver; Håkan Olsson; Kelly-Anne Phillips; Mary Beth Terry; David E Goldgar; Karin Kast; Christoph Engel; Thea M Mooij; Julian Adlard; Daniel Barrowdale; Rosemarie Davidson; Ros Eeles; Steve Ellis; D Gareth Evans; Debra Frost; Louise Izatt; Mary E Porteous; Lucy E Side; Lisa Walker; Pascaline Berthet; Valérie Bonadona; Dominique Leroux; Emmanuelle Mouret-Fourme; Laurence Venat-Bouvet; Saundra S Buys; Melissa C Southey; Esther M John; Wendy K Chung; Mary B Daly; Anita Bane; Christi J van Asperen; Encarna B Gómez Garcia; Marian J E Mourits; Theo A M van Os; Marie-José Roos-Blom; Michael L Friedlander; Sue-Anne McLachlan; Christian F Singer; Yen Y Tan; Lenka Foretova; Marie Navratilova; Anne-Marie Gerdes; Trinidad Caldes; Jacques Simard; Edith Olah; Anna Jakubowska; Brita Arver; Ana Osorio; Catherine Noguès; Nadine Andrieu; Douglas F Easton; Flora E van Leeuwen; John L Hopper; Roger L Milne; Antonis C Antoniou; Matti A Rookus
Journal:  JNCI Cancer Spectr       Date:  2018-06-28

8.  Accelerated Accumulation of Multimorbidity After Bilateral Oophorectomy: A Population-Based Cohort Study.

Authors:  Walter A Rocca; Liliana Gazzuola-Rocca; Carin Y Smith; Brandon R Grossardt; Stephanie S Faubion; Lynne T Shuster; James L Kirkland; Elizabeth A Stewart; Virginia M Miller
Journal:  Mayo Clin Proc       Date:  2016-09-29       Impact factor: 7.616

9.  Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study.

Authors:  Marthe M de Jonge; Cornelis D de Kroon; Denise J Jenner; Jan Oosting; Joanne A de Hullu; Marian J E Mourits; Encarna B Gómez Garcia; Margreet G E M Ausems; J Margriet Collée; Klaartje van Engelen; Irma van de Beek; Vincent T H B M Smit; Matti A Rookus; Geertruida H de Bock; Flora E van Leeuwen; Tjalling Bosse; Olaf M Dekkers; Christi J van Asperen
Journal:  J Natl Cancer Inst       Date:  2021-09-04       Impact factor: 13.506

10.  Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits.

Authors:  Lieske H Schrijver; Thea M Mooij; Anouk Pijpe; Gabe S Sonke; Marian J E Mourits; Nadine Andrieu; Antonis C Antoniou; Douglas F Easton; Christoph Engel; David Goldgar; Esther M John; Karin Kast; Roger L Milne; Håkan Olsson; Kelly-Anne Phillips; Mary Beth Terry; John L Hopper; Flora E van Leeuwen; Matti A Rookus
Journal:  J Natl Cancer Inst       Date:  2022-04-11       Impact factor: 13.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.